These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
242 related articles for article (PubMed ID: 35109912)
1. A glycolysis-related two-gene risk model that can effectively predict the prognosis of patients with rectal cancer. Liu Z; Liu Z; Zhou X; Lu Y; Yao Y; Wang W; Lu S; Wang B; Li F; Fu W Hum Genomics; 2022 Feb; 16(1):5. PubMed ID: 35109912 [TBL] [Abstract][Full Text] [Related]
2. Identification of a novel glycolysis-related gene signature for predicting the survival of patients with colon adenocarcinoma. Yi K; Wu J; Tang X; Zhang Q; Wang B; Wang F Scand J Gastroenterol; 2022 Feb; 57(2):214-221. PubMed ID: 34644216 [TBL] [Abstract][Full Text] [Related]
3. Mining novel cell glycolysis related gene markers that can predict the survival of colon adenocarcinoma patients. Chen S; Cao G; Wu W; Lu Y; He X; Yang L; Chen K; Chen B; Xiong M Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32744303 [TBL] [Abstract][Full Text] [Related]
4. Identification of a glycolysis- and lactate-related gene signature for predicting prognosis, immune microenvironment, and drug candidates in colon adenocarcinoma. Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Peng J; Xie Y Front Cell Dev Biol; 2022; 10():971992. PubMed ID: 36081904 [No Abstract] [Full Text] [Related]
5. An Intratumor Heterogeneity-Related Signature for Predicting Prognosis, Immune Landscape, and Chemotherapy Response in Colon Adenocarcinoma. Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Xie Y Front Med (Lausanne); 2022; 9():925661. PubMed ID: 35872794 [TBL] [Abstract][Full Text] [Related]
6. Construction of a novel choline metabolism-related signature to predict prognosis, immune landscape, and chemotherapy response in colon adenocarcinoma. Liu C; Liu D; Wang F; Liu Y; Xie J; Xie J; Xie Y Front Immunol; 2022; 13():1038927. PubMed ID: 36451813 [TBL] [Abstract][Full Text] [Related]
7. Identification of sixteen metabolic genes as potential biomarkers for colon adenocarcinoma. Zhao F; Liu Y; Gu X; Zhang B; Song C; Cui B J BUON; 2021; 26(4):1252-1259. PubMed ID: 34564978 [TBL] [Abstract][Full Text] [Related]
8. A Prognostic Model Based on the Immune-related Genes in Colon Adenocarcinoma. Sun YL; Zhang Y; Guo YC; Yang ZH; Xu YC Int J Med Sci; 2020; 17(13):1879-1896. PubMed ID: 32788867 [No Abstract] [Full Text] [Related]
9. A potential prognostic prediction model of colon adenocarcinoma with recurrence based on prognostic lncRNA signatures. Jin L; Li C; Liu T; Wang L Hum Genomics; 2020 Jun; 14(1):24. PubMed ID: 32522293 [TBL] [Abstract][Full Text] [Related]
10. Identification of 9 Gene Signatures by WGCNA to Predict Prognosis for Colon Adenocarcinoma. Yang M; He H; Peng T; Lu Y; Yu J Comput Intell Neurosci; 2022; 2022():8598046. PubMed ID: 35392038 [TBL] [Abstract][Full Text] [Related]
11. Identification of a Four-Gene Metabolic Signature to Evaluate the Prognosis of Colon Adenocarcinoma Patients. Zheng Y; Wu R; Wang X; Yin C Front Public Health; 2022; 10():860381. PubMed ID: 35462848 [TBL] [Abstract][Full Text] [Related]
12. Development of a prognostic model for personalized prediction of colon adenocarcinoma (COAD) patient outcomes using methylation-driven genes. Chen D; Zhang B; Kang K; Li L; Liao Y; Qing S; Di Y J Appl Genet; 2023 Dec; 64(4):713-721. PubMed ID: 37589877 [TBL] [Abstract][Full Text] [Related]
13. Development of a 5-mRNAsi-related gene signature to predict the prognosis of colon adenocarcinoma. Huang H; Lu L; Li Y; Chen X; Li M; Yang M; Huang X PeerJ; 2023; 11():e16477. PubMed ID: 38025763 [TBL] [Abstract][Full Text] [Related]
14. Identification of necroptosis-related genes for predicting prognosis and exploring immune infiltration landscape in colon adenocarcinoma. Wang Y; Lin MG; Meng L; Chen ZM; Wei ZJ; Ying SC; Xu A Front Oncol; 2022; 12():941156. PubMed ID: 36505813 [TBL] [Abstract][Full Text] [Related]
15. A novel signature model based on mitochondrial-related genes for predicting survival of colon adenocarcinoma. Gao H; Xing F BMC Med Inform Decis Mak; 2022 Oct; 22(1):277. PubMed ID: 36273131 [TBL] [Abstract][Full Text] [Related]
16. Identification of DLL3-related genes affecting the prognosis of patients with colon adenocarcinoma. Xiang J; Gong W; Liu J; Zhang H; Li M; Wang R; Lv Y; Sun P Front Genet; 2023; 14():1098190. PubMed ID: 37274780 [No Abstract] [Full Text] [Related]
17. Prognostic value of a novel glycolysis-related gene expression signature for gastrointestinal cancer in the Asian population. Xia R; Tang H; Shen J; Xu S; Liang Y; Zhang Y; Gong X; Min Y; Zhang D; Tao C; Wang S; Zhang Y; Yang J; Wang C Cancer Cell Int; 2021 Mar; 21(1):154. PubMed ID: 33663535 [TBL] [Abstract][Full Text] [Related]
18. Exploration of Potential Roles of m5C-Related Regulators in Colon Adenocarcinoma Prognosis. Huang Y; Huang C; Jiang X; Yan Y; Zhuang K; Liu F; Li P; Wen Y Front Genet; 2022; 13():816173. PubMed ID: 35281843 [No Abstract] [Full Text] [Related]
19. MicroRNA-Related Prognosis Biomarkers from High-Throughput Sequencing Data of Colorectal Cancer. Xing XL; Yao ZY; Zhang T; Zhu N; Liu YW; Peng J Biomed Res Int; 2020; 2020():7905380. PubMed ID: 32964043 [TBL] [Abstract][Full Text] [Related]
20. A Risk Model for Prognosis and Treatment Response Prediction in Colon Adenocarcinoma Based on Genes Associated with the Characteristics of the Epithelial-Mesenchymal Transition. Huang H; Li T; Meng Z; Zhang X; Jiang S; Suo M; Li N Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686013 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]